Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05907681

Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)

This study is a prospective observational study on outcomes of high precision hypo-fractionated radiotherapy in breast cancer with distant metastasis.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Breast Cancer Breast Diseases Breast Neoplasms Metastatic Breast Cancer Neoplasms Neoplasms by Site Radiation Therapy Complication Skin Diseases Skin and Connective Tissue Diseases

Age range

19 year–100 year

Sex eligibility

Female

Study type

Observational

Primary location

Samsung Medical Center

Seoul, South Korea

Location status: Recruiting

Location contact

Won Park

CONTACT

[email protected]

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • histologically confirmed breast cancer
  • presence of distant metastasis
  • radiation therapy using IMRT, SBRT, or proton therapy is done or planned
  • Able and willing to comply with the study protocol

Exclusion criteria

  • unable to adhere to the study protocol

Treatment and study plan

Primary outcomes

  1. Local control rate

    Time frame: 1-year

    LC after radiation therapy

Secondary outcomes

  1. Overall survival rate

    Time frame: 1-year

  2. Disease-free survival

    Time frame: 1-year

    disease-free survival rate after the time of RT

  3. Treatment-related toxicities

    Time frame: 1-year

    Acute and chronic radiation toxicities according to CTCAE v5.0

Study contacts

Contact information is provided by the study sponsor or research team.

Haeyoung Kim

CONTACT

[email protected]

+82-02-3410-2612

won kyung Cho

CONTACT

[email protected]

+821087328703

Sponsors and collaborators

Lead sponsor

Samsung Medical Center

Other

Registry information

Important dates

Study start
2023
Primary completion
2028
Study completion
2033
First posted
Jun 18, 2023
Registry last updated
Jun 29, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.